I-Mab Biopharma
IMAB
#9150
Rank
C$0.10 B
Marketcap
$1.33
Share price
-3.17%
Change (1 day)
-35.50%
Change (1 year)

I-Mab Biopharma (IMAB) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$21.24 Million

According to I-Mab Biopharma's latest financial reports the company's total liabilities are C$21.24 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

I-Mab Biopharma - Total liabilities on balance sheet (from 2024 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$0.22 B9.91%
2021-12-31C$0.20 B50.8%
2020-12-31C$0.13 B-80.41%
2019-12-31C$0.70 B6.89%
2018-12-31C$0.65 B157.64%
2017-12-31C$0.25 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$17.45 M-17.85%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.22 B 5,661.78%๐Ÿ‡บ๐Ÿ‡ธ USA